Anti-Mouse PD-L2 (B7-DC) - Purified

Leinco Technologies
Product Code: LEI-C2142
Product Group: Primary Antibodies
CodeSizePrice
LEI-C2142-500ug500 ug£183.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rat
Antibody Isotype: IgG2a κ
Antibody Clonality: Monoclonal
Antibody Clone: TY25
Regulatory Status: RUO
Target Species: Mouse
Applications:
  • Flow Cytometry
  • Immunohistochemistry- Frozen Section (IHC-F)
  • Immunoprecipitation (IP)
  • Western Blot (WB)
Shipping:
2-8°C
Storage:
This purified antibody is stable when stored at 2-8°C. Do not freeze.

Further Information

Antigen Distribution:
PD-L2 is expressed on macrophages and a subset of dendritic cells (DCs).
Concentration:
0.5 mg/ml
Conjugate/Tag/Label:
Purified
Format:
This purified antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Formulation:
This purified antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Immunogen:
Purified transfected mouse B7-DC cell line
Long Description:
PD-L2 antibody, clone TY25, recognizes mouse programmed death ligand 2 (PDL-2), also known as B7-DC and CD273. PD-L2 is a 42 kDa type I transmembrane glycoprotein that belongs to the B7 family of the immunoglobulin (Ig) receptor superfamily. PD-L2 is an inhibitory ligand primarily expressed on antigen-presenting cells, including macrophages and a subset of dendritic cells (DCs). Its receptor, PD-1, is expressed by CD4-CD8- thymocytes as well as CD4 and CD8 T cells, monocytes, DCs, and B cells upon activation1. Binding of PD-L2 to PD-1 on CD4 and CD8 T cells inhibits T cell receptor (TCR) signaling, negatively regulating T cell proliferation, cytokine production, and cytotoxic activity2. PD-L2 is expressed on many tumor types3,4 and is associated with unfavorable prognosis in patients with solid tumors5.
NCBI Gene:
58205
Target:
PD-L2

References

1. Francisco LM, et al. (2010) Immunol Rev. 236:219-242 2. Latchman Y, et al. (2001) Nat Immunol. 2(3):261-8 3. Ahmad SM, et al. (2018) Oncoimmunology. 7:e1390641 4. Panjwani PK, et al. (2018) Hum Pathol. 71:91?9 5. Yang H, et al. (2019) Front Oncol. 9:47

Related Products

Product NameProduct CodeSupplier 
Anti-Mouse/Human CD273 (PD-L2) - Purified in vivo GOLD™ Functional GradeLEI-P379Leinco Technologies Summary Details